- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03390894
Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group.
Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years
Study Overview
Status
Conditions
Detailed Description
One consequence of the improvement in survival rates of certain tumors such as breast cancer is the increase in the number of patients available for long-term follow-up in randomized controlled clinical trials. This long follow-up allows an additional long-term evaluation of the efficacy, as well as of the sequelae related to the treatments that may occur beyond the time of the primary analysis.
The target population of the study are all patients who were included in neoadjuvant and adjuvant clinical trials of GEICAM performed by the goup since 1998 in the medical oncology units of the participating sites, ensuring a follow-up of patients of approximately 30 years. This will allow to describe the long-term evolution of the patients with invasive breast cancer in early stages.
The information obtained will be very useful to professionals involved in the diagnosis, treatment and monitoring of breast cancer, hospital managers, patients with this condition and society in general. This study provides data of great interest for the estimation of long-term disease requirements.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Study Project Manager
- Phone Number: 00346592870
- Email: inicio_ensayos@geicam.org
Study Contact Backup
- Name: Start-Up Unit Manager
- Phone Number: 00346592870
- Email: inicio_ensayos@geicam.org
Study Locations
-
-
-
A Coruña, Spain
- Recruiting
- Centro Oncologico de Galicia
-
A Coruña, Spain
- Recruiting
- Complejo Hospitalario A Coruña
-
Albacete, Spain
- Recruiting
- Complejo Hospitalario Universitario de Albacete
-
Alicante, Spain
- Recruiting
- Hospital General Universitario de Elche
-
Alicante, Spain
- Recruiting
- Hospital General Universitario de Alicante
-
Alicante, Spain
- Recruiting
- Hospital General Universitario de Elda
-
Alicante, Spain
- Recruiting
- Hospital Virgen de los Lirios
-
Badajoz, Spain
- Recruiting
- Hospital Infanta Cristina
-
Badalona, Spain
- Recruiting
- Hospital Universitari Germans Trias i Pujol
-
Barcelona, Spain
- Recruiting
- Hospital del Mar
-
Barcelona, Spain
- Recruiting
- Hospital De La Santa Creu I Sant Pau
-
Barcelona, Spain
- Recruiting
- Hospital Clinic i Provincial
-
Barcelona, Spain
- Recruiting
- Consorci Sanitari de Terrassa
-
Barcelona, Spain
- Recruiting
- Hospital Universitario Mútua Terrassa
-
Barcelona, Spain
- Recruiting
- Instituto Catalán Oncología Barcelona Hospital Duran I Reynalds
-
Bilbao, Spain
- Recruiting
- Hospital Universitario de Basurto
-
Burgos, Spain
- Recruiting
- Hospital Universitario de Burgos
-
Cadiz, Spain
- Recruiting
- Complejo Especialidades de Jerez de la Frontera
-
Castelló, Spain
- Recruiting
- Complejo Hospitalario de Castellón
-
Cuenca, Spain
- Recruiting
- Hospital Virgen de la Luz
-
Cádiz, Spain
- Recruiting
- Hospital Universitario Puerta del Mar
-
Córdoba, Spain
- Recruiting
- Hospital Universitario Reina Sofía
-
Donostia, Spain
- Recruiting
- Onkologikoa
-
Donostia, Spain
- Recruiting
- Hospital Universitario Donostia
-
Donostia, Spain
- Recruiting
- Hospital Universitario de Cruces
-
Gerona, Spain
- Recruiting
- Instituto Catalán de Oncología Gerona Hospital Dr. Josep Trueta
-
Granada, Spain
- Recruiting
- Hospital Universitario Virgen de las Nieves
-
Granada, Spain
- Recruiting
- Hospital Universitario San Cecilio
-
Guadalajara, Spain
- Recruiting
- Hospital Universitario de Guadalajara
-
Huelva, Spain
- Recruiting
- Complejo Hospitalario de Especialidades Juan Ramón Jiménez
-
Jaén, Spain
- Recruiting
- Complejo Hospitalario de Jaén
-
León, Spain
- Recruiting
- Hospital de Leon
-
Lugo, Spain
- Recruiting
- Hospital Universitario Lucus Augusti
-
Madrid, Spain
- Recruiting
- Hospital Universitario 12 de octubre
-
Madrid, Spain
- Recruiting
- Hospital General Universitario Gregorio Marañon
-
Madrid, Spain
- Recruiting
- Hospital Universitario La Paz
-
Madrid, Spain
- Recruiting
- Hospital Universitario Ramón y Cajal
-
Madrid, Spain
- Recruiting
- Hospital Universitario Fundación Alcorcón
-
Madrid, Spain
- Not yet recruiting
- Hopsital Clínico San Carlos
-
Madrid, Spain
- Not yet recruiting
- Hospital Madrid Montepricipe
-
Madrid, Spain
- Not yet recruiting
- MD Anderson Cancer Center
-
Madrid, Spain
- Recruiting
- Hospital Universitario La Princesa
-
Madrid, Spain
- Recruiting
- Hospital Universitario Severo Ochoa
-
Madrid, Spain
- Recruiting
- Hospital De Mostoles
-
Madrid, Spain
- Recruiting
- Hospital Universitario Fuenlabrada
-
Manresa, Spain
- Recruiting
- ALTHAIA Xarxa Asistencial Universitària Manresa
-
Murcia, Spain
- Recruiting
- Hospital Clínico Universitario Virgen de la Arrixaca
-
Murcia, Spain
- Recruiting
- Hospital General Universitario Jose Maria Morales Meseguer
-
Málaga, Spain
- Recruiting
- Hospital Universitario Virgen de la Victoria
-
Málaga, Spain
- Recruiting
- Hospital Regional de Málaga Carlos Haya
-
Orense, Spain
- Recruiting
- Hospital Santa María Nai
-
Palencia, Spain
- Not yet recruiting
- Complejo Hospitalario de Palencia
-
Palmas de Gran Canaria, Spain
- Not yet recruiting
- Complejo Hospitalario Universitario de Gran Canaria Dr. Negrín
-
Pontevedra, Spain
- Recruiting
- Hospital Alvaro Cunqueiro
-
Sabadell, Spain
- Recruiting
- Corporacion Sanitaria Parc Tauli
-
Salamanca, Spain
- Recruiting
- Hospital Universitario de Salamanca
-
Sevilla, Spain
- Recruiting
- Hospital Universitario de Valme
-
Tarragona, Spain
- Recruiting
- Hospital Universitario Sant Joan de Reus
-
Tenerife, Spain
- Not yet recruiting
- Hospital Nuestra Señora de La Candelaria
-
Toledo, Spain
- Recruiting
- Hospital Virgen de la Salud
-
Valencia, Spain
- Recruiting
- Hospital General Universitario de Valencia
-
Valencia, Spain
- Recruiting
- Hospital Clinico Universitario de Valencia
-
Valencia, Spain
- Recruiting
- Hospital Universitari i Politecnic La Fe
-
Valencia, Spain
- Recruiting
- Fundacion Instituto Valenciano de Oncologia
-
Valencia, Spain
- Recruiting
- Hospital Arnau Vilanova
-
Valencia, Spain
- Recruiting
- Hospital de Sagunto
-
Valencia, Spain
- Recruiting
- Hospital Universitario Dr. Peset Aleixandre
-
Vitoria, Spain
- Recruiting
- Hospital de Txagorritxu
-
Zaragoza, Spain
- Recruiting
- Hospital Universitario Miguel Servet
-
Zaragoza, Spain
- Recruiting
- Hospital Clínico Universitario de Zaragoza Lozano Blesa
-
-
Asturias
-
Avilés, Asturias, Spain
- Recruiting
- Hospital San Agustín Avilés
-
-
Navarra
-
Pamplona, Navarra, Spain
- Not yet recruiting
- Complejo Hospitalario de Navarra
-
-
Tenerife
-
La Laguna, Tenerife, Spain
- Not yet recruiting
- Hospital Universitario de Canarias
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected.
- Patients whose death or contact loss has not been previously collected in the databases of the original studies.
Exclusion Criteria:
- Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Event Free Survival (EvFS) in neoadjuvant studies.
Time Frame: Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
The EvFS, is defined as the time from the randomization of the patients in the studies of origin, to the date of one of the following events:
|
Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
|
Disease Free Survival (DFS) in adjuvant studies.
Time Frame: Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
DFS is defined as the time from the date of randomization of patients in the studies of origin, to the date of one of the following events:
|
Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Survival (OS).
Time Frame: Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
Overall Survival (OS) defined as the time from the date of study enrolment to the date of death from any cause.
|
Throughout the whole follow up. Up to 30 years from the beginning of the Study approximately.
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Study Director, Complejo Hospitalario de Especialidades Virgen de la Victoria
- Study Director: Study Director, Hospital General Universitario Gregorio Marañon
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GEICAM/2016-03
- 2017-002850-35 (EudraCT Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Invasive Breast Cancer Early Stages
-
China Medical University HospitalRecruitingBreast Cancer Stage III | Breast Cancer Stages I | Breast Cancer Stages IITaiwan
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
University of Illinois at ChicagoRecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | High Risk Breast CarcinomaUnited States
-
Stanford UniversityNational Institutes of Health (NIH); University of California; Breast Cancer... and other collaboratorsCompletedBreast Cancer | Breast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)United States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Stanford UniversityCalifornia Breast Cancer Research ProgramCompletedDepression | Breast Cancer | Stress | Breast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast CancerUnited States
-
Alejandra García-NovoaRecruitingBreast Cancer Non-invasive Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | High Risk Breast CarcinomaSpain
-
Jonsson Comprehensive Cancer CenterDaiichi Sankyo Co., Ltd.; Translational Research in Oncology-U.SRecruitingInvasive Breast Cancer | Stage II Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Early-stage Breast Cancer | Stage III Breast CancerUnited States
-
University of UtahCelgene CorporationTerminatedStages II-III Breast CancerUnited States
-
Wenjin YinActive, not recruitingBreast Cancer InvasiveChina